New Study Links Deep Brain Stimulation to High Beta Rhythm in Parkinson’s Treatment

Recent research has enhanced understanding of deep brain stimulation (DBS) as a therapy for movement issues caused by Parkinson’s disease. The study highlights the effectiveness of DBS in stimulating a specific brain network operating through a fast beta rhythm ranging from 20 to 35 Hz. This pivotal insight was produced by an interdisciplinary team from the University Hospitals of Cologne and Düsseldorf, Harvard Medical School, and Charité Berlin, and is published in the journal Brain.

Characterizing the DBS Response Network

Professor Dr. Andreas Horn, a computational neurologist from the University of Cologne and the study’s lead author, stated, “For the first time, we were able to characterize the DBS response network in Parkinson’s disease in terms of space and time, simultaneously.” He emphasized that targeting a precisely defined network improves treatment outcomes for Parkinson’s patients.

DBS of the subthalamic nucleus has been an established method for alleviating motor symptoms in those affected by Parkinson’s. This procedure employs implanted electrodes to send small electrical pulses to deep brain regions. However, prior research had only partially elucidated how stimulation works. While brain imaging identified effective stimulation areas, and electrophysiological studies determined signal frequencies, there had previously been no synchronized data capturing both spatial locations and signal timings.

Mapping Connections in the Brain

The study examined a diverse sample of fifty patients and one hundred brain hemispheres, employing a combination of implanted DBS electrodes and magnetoencephalography (MEG) to record brain activity. This allowed the researchers to map functional connections between deep and surface brain regions.

The analysis found that the network linking the subthalamic nucleus with frontal brain areas predominantly communicates at a high beta frequency of 20-35 Hz. Notably, the strength of this connection corresponded with the degree of improvement in motor symptoms experienced by individual patients post-electrode implantation.

Implications for Future DBS Treatments

Dr. Bahne Bahners, the study’s first author from Düsseldorf University Hospital, explained, “These results suggest that a certain rhythm of the brain acts as a communication channel between the subthalamic nucleus and the cerebral cortex and may mediate the therapeutic effects of deep brain stimulation.” This insight may pave the way for more accurate adjustment of DBS settings, especially for patients who haven’t achieved optimal benefits from the current treatment.

The findings provide an initial foundation for personalizing deep brain stimulation according to an individual patient’s brain network, especially in cases where existing DBS settings fail to yield sufficient symptom relief. Researchers are also set to investigate how DBS induces changes in brain networks, with studies examining these causal effects already in progress.

This research was supported in large part by the Professor Klaus Thiemann Foundation.